Evolution of poor reporting and inadequate methods over time in 20 920 randomised controlled trials included in Cochrane reviews: research on research study
- PMID: 28596181
- DOI: 10.1136/bmj.j2490
Evolution of poor reporting and inadequate methods over time in 20 920 randomised controlled trials included in Cochrane reviews: research on research study
Erratum in
-
Evolution of poor reporting and inadequate methods over time in 20 920 randomised controlled trials included in Cochrane reviews: research on research study.BMJ. 2017 Aug 8;358:j3806. doi: 10.1136/bmj.j3806. BMJ. 2017. PMID: 28790032 No abstract available.
Abstract
Objective To examine how poor reporting and inadequate methods for key methodological features in randomised controlled trials (RCTs) have changed over the past three decades.Design Mapping of trials included in Cochrane reviews.Data sources Data from RCTs included in all Cochrane reviews published between March 2011 and September 2014 reporting an evaluation of the Cochrane risk of bias items: sequence generation, allocation concealment, blinding, and incomplete outcome data.Data extraction For each RCT, we extracted consensus on risk of bias made by the review authors and identified the primary reference to extract publication year and journal. We matched journal names with Journal Citation Reports to get 2014 impact factors.Main outcomes measures We considered the proportions of trials rated by review authors at unclear and high risk of bias as surrogates for poor reporting and inadequate methods, respectively.Results We analysed 20 920 RCTs (from 2001 reviews) published in 3136 journals. The proportion of trials with unclear risk of bias was 48.7% for sequence generation and 57.5% for allocation concealment; the proportion of those with high risk of bias was 4.0% and 7.2%, respectively. For blinding and incomplete outcome data, 30.6% and 24.7% of trials were at unclear risk and 33.1% and 17.1% were at high risk, respectively. Higher journal impact factor was associated with a lower proportion of trials at unclear or high risk of bias. The proportion of trials at unclear risk of bias decreased over time, especially for sequence generation, which fell from 69.1% in 1986-1990 to 31.2% in 2011-14 and for allocation concealment (70.1% to 44.6%). After excluding trials at unclear risk of bias, use of inadequate methods also decreased over time: from 14.8% to 4.6% for sequence generation and from 32.7% to 11.6% for allocation concealment.Conclusions Poor reporting and inadequate methods have decreased over time, especially for sequence generation and allocation concealment. But more could be done, especially in lower impact factor journals.
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.
Conflict of interest statement
Competing interests: DM is a member of the Cochrane Library Oversight Committee and a member of the Cochrane Bias Methods Group. He received funding from the Cochrane Collaboration for an unrelated project. IB and DGA are also members of the Cochrane Bias Methods Group. DGA is supported by Cancer Research UK (C5529). KD is the director of the US Cochrane Center. PR is the director of Cochrane France. The other authors declare no competing interests.
Similar articles
-
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217. Cochrane Database Syst Rev. 2022. PMID: 36321557 Free PMC article.
-
The methodological quality of 176,620 randomized controlled trials published between 1966 and 2018 reveals a positive trend but also an urgent need for improvement.PLoS Biol. 2021 Apr 19;19(4):e3001162. doi: 10.1371/journal.pbio.3001162. eCollection 2021 Apr. PLoS Biol. 2021. PMID: 33872298 Free PMC article.
-
Risk of bias assessment of randomised controlled trials referenced in the 2015 American Heart Association guidelines update for cardiopulmonary resuscitation and emergency cardiovascular care: a cross-sectional review.BMJ Open. 2019 May 5;9(5):e023725. doi: 10.1136/bmjopen-2018-023725. BMJ Open. 2019. PMID: 31061016 Free PMC article.
-
Do randomized clinical trials with inadequate blinding report enhanced placebo effects for intervention groups and nocebo effects for placebo groups?Syst Rev. 2014 Feb 21;3:14. doi: 10.1186/2046-4053-3-14. Syst Rev. 2014. PMID: 24555576 Free PMC article.
-
Influence of reported study design characteristics on intervention effect estimates from randomised controlled trials: combined analysis of meta-epidemiological studies.Health Technol Assess. 2012 Sep;16(35):1-82. doi: 10.3310/hta16350. Health Technol Assess. 2012. PMID: 22989478 Review.
Cited by
-
Serious Concerns About the RCT Study Quality of Traditional Chinese Medicine Injections for Treating Cardiovascular Diseases and COVID-19.Cardiovasc Drugs Ther. 2021 Feb;35(1):191-193. doi: 10.1007/s10557-020-07053-2. Epub 2020 Aug 12. Cardiovasc Drugs Ther. 2021. PMID: 32785792 Free PMC article. No abstract available.
-
Do thermal treatments affect the mechanical behavior of porcelain-veneered zirconia? A systematic review and meta-analysis.Dent Mater. 2019 May;35(5):807-817. doi: 10.1016/j.dental.2019.02.016. Epub 2019 Mar 4. Dent Mater. 2019. PMID: 30846374 Free PMC article.
-
Standards for design and measurement would make clinical research reproducible and usable.Proc Natl Acad Sci U S A. 2018 Mar 13;115(11):2590-2594. doi: 10.1073/pnas.1708273114. Proc Natl Acad Sci U S A. 2018. PMID: 29531086 Free PMC article. Review.
-
Simple decision-tree tool to facilitate author identification of reporting guidelines during submission: a before-after study.Res Integr Peer Rev. 2017 Dec 18;2:20. doi: 10.1186/s41073-017-0044-9. eCollection 2017. Res Integr Peer Rev. 2017. PMID: 29451534 Free PMC article.
-
Risk of Bias in Iranian Randomized Trials Included in Cochrane Reviews.Arch Iran Med. 2022 Jun 1;25(6):375-382. doi: 10.34172/aim.2022.61. Arch Iran Med. 2022. PMID: 35943017 Free PMC article.
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous